Amendment H-8166 to HF 2591
Relating to Lyme disease, including notice and consent provisions required for Lyme disease testing, and continuing education requirements for health care providers
Never voted onStrike everything: replaces the whole bill
Filed March 6, 2024 in the House by
What it changes
AI summary This amendment replaces the entire bill to require doctors to provide specific written information about the risks of inaccurate Lyme disease test results. It also adds a rule that protects these healthcare providers from being sued for providing this information, unless they are guilty of gross negligence or willful misconduct.1
Read the amendment’s wording
- By striking everything after the enacting clause and inserting: “Section
- NEW SECTION . 135.194 Lyme disease testing information —— immunity.
- A health care provider who orders a laboratory test for the presence of Lyme disease shall provide the patient, or the patient’s legal representative, with the following information: According to the centers for disease control and prevention, as of 2011, Lyme disease is the sixth fastest growing disease in the United States. Your health care provider has ordered a laboratory test for the presence of Lyme disease for you. Current laboratory testing for Lyme disease can be problematic and standard laboratory tests often result in false negative and false positive results and, if performed too early, you may not have produced enough antibodies to be considered positive because your immune response requires time to develop antibodies. If you are tested for the presence of Lyme disease and the results are negative, this does not necessarily mean you do not have Lyme disease. If you continue to experience symptoms, you should contact your health care provider and inquire about the appropriateness of retesting or additional treatment.
- A health care provider shall be immune from civil liability for providing written information in compliance with this section, except in the case of gross negligence or willful misconduct.
- For the purposes of this section, “health care provider” means a physician licensed to practice under chapter 148 or an individual who orders a laboratory test for Lyme disease under the authorization of the licensed physician.”
- Title page, by striking lines 1 through 3 and inserting “An Act relating to the provision of Lyme disease information by a health care provider, and providing immunity.”